Oncorus Inc. (ONCR) Social Stream



Oncorus Inc. (ONCR): $0.13

0.00 (-3.08%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add ONCR to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#305 of 407

in industry

ONCORUS INC (ONCR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ONCORUS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 3 $40 $29 $34.666 $0.121 28549.59%
2021-11-15 3 $40 $19 $31.333 $0.121 25795.04%
2022-03-09 2 $40 $19 $26.333 $0.121 21662.81%
2022-03-28 3 $40 $7 $21.5 $0.121 17668.6%
2022-05-04 4 $40 $7 $18.25 $0.121 14982.64%
2022-05-18 4 $19 $7 $11.25 $0.121 9197.52%
2022-06-15 5 $19 $5 $10 $0.121 8164.46%
2022-08-15 3 $19 $5 $10.75 $0.121 8784.3%
2022-11-07 4 $7 $5 $6 $0.121 4858.68%
2022-11-30 4 $7 $2 $4.5 $0.121 3619.01%
2023-03-24 4 $1.5 $1.5 $1.5 $0.121 1139.67%
NA 3 $NA $NA $NA $0.121 NA%

The Trend in the Analyst Price Target


ONCR's average price target has moved down $36.25 over the prior 20 months.

ONCR reports an average of 744.62% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-15 4 19.0 5.0 10.75 1.310 720.61%
2022-08-06 4 19.0 5.0 10.75 1.520 607.24%
2022-11-07 4 7.0 5.0 6.00 0.600 900%
2022-11-30 4 7.0 2.0 4.50 0.480 837.5%
2023-03-24 4 1.5 1.5 1.50 0.337 345.1%

ONCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.5 1 0 3 0 0 4

The Trend in the Broker Recommendations


ONCR's average broker recommendation rating worsened by 1.5 over the prior 43 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ONCORUS INC's upside potential (average analyst target price relative to current price) is higher than 1694.29% of all US stocks.
  • ONCR has a higher number of analysts covering the stock than 233.17% of all US stocks.
  • ONCR has a lower variance in analysts' estimates than -1124.09% of stocks in the small market cap category.
  • ONCORUS INC's average analyst price target is higher than 634.04% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ONCORUS INC are KRON, SPRB, and MLTX.

Is ONCR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!